3545 results for «229»

Filter By

3545 results

The cathlab of tomorrow... already here today

18 May 2022 – From EuroPCR 2022

Explore the 3 key pillars of innovation and discover how AI can improve patient safety and aid decision-making in the cathlab, what are the latest updates in robotic PCI and how it can be the transformative technology, and how technology can have a huge impact on...

The cathlab of tomorrow... already here today

Transcatheter tricuspid valve replacement - Where are we in Latin America?

12 Sep 2025 – From PCR Rio Valves 2025

Stay abreast of the latest advances in transcatheter tricuspid valve replacement (TTVR) across Latin America. This session highlights orthotopic implant technologies, patient selection criteria, early clinical outcomes, and discusses future perspectives including training, technology access, and regional clinical impact.

Transcatheter tricuspid valve replacement - Where are we in Latin America?

Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction: vascular healing outcomes from the MAGSTEMI trial

27 Dec 2020

The MAGSTEMI trial showed larger endothelium-independent vasodilatation with magnesium-based bioresorbable scaffolds (MgBRS) than with sirolimus-eluting stents (SES). However, restenosis was more frequent with MgBRS. The aims of this study were to compare the healing pattern between MgBRS and SES and to describe the main causes of...

Authors :

J. Gomez-Lara, L. Ortega-Paz, S. Brugaletta, J. Cuesta, S. Romaní, A. Serra, P. Salinas, B. García del Blanco, J. Goicolea, R. Hernandez-Antolín, P. Antuña, R. Romaguera, A. Regueiro, F. Rivero, Àngel Cequier, F. Alfonso, J.Antoni Gómez-Hospital, M. Sabaté
EuroIntervention: BRS versus permanent sirolimus-eluting stents in patients with STEMI: vascular healing outcomes from the MAGSTEMI trial

No go (again) for oral anticoagulation after TAVR: Results of the ADAPT-TAVR trial

04 Apr 2022

Francesco Costa analyses the results of ADAPT-TAVR, a prospective randomized trial on edoxaban vs dual antiplatelet therapy for valve thrombosis and cerebral thromboembolism after transcatheter aortic-valve replacement.

Francesco Costa

Author

Francesco Costa
A Randomized ADAPT-TAVR Trial: Edoxaban Vs DAPT For Valve Thrombosis and Cerebral Thromboembolism After TAVR

TRILUMINATE pivotal: A landmark randomized clinical trial of transcatheter tricuspid valve edge-to-edge repair for tricuspid regurgitation

04 Mar 2023

Jonathan Curio and Alex Sticchi provide their take on this clinical trial which was presented by Paul Sorajja at the American College of Cardiology Scientific Session (ACC.23/WCC).

Alessandro Sticchi

Author

Alessandro Sticchi
Jonathan Curio

Author

Jonathan Curio
Live from ACC.23/WCC: TRILUMINATE pivotal
Didn’t find what you were looking for?